NYSE$MOH

Molina Healthcare Inc · Q3 2023 earnings

Q3 2023 earnings · · Investor relations

Briefing

Molina Healthcare reported Q3 2023 financial results, with GAAP earnings per diluted share of $4.21 and adjusted earnings per diluted share of $5.05.

Molina Healthcare reported a strong third quarter, with an 8% increase in premium revenue and a 7% increase in GAAP net income per diluted share. The company affirmed its full-year 2023 adjusted earnings guidance of at least $20.75 per diluted share.

  • Served approximately 5.2 million members, an increase of 1% year over year.
  • Premium revenue increased by 8% year over year to approximately $8.2 billion.
  • GAAP net income increased by 7% year over year to $4.21 per diluted share.
  • Adjusted net income increased by 16% year over year to $5.05 per diluted share.

Headline financials

Total Revenue

$8.55B

Previous: $7.93B+7.8%
EPS (adj)

$5.05

Previous: $4.36+15.8%
Total Membership

5.2M

Previous: 5.2M+0.1%
Medicaid Membership

4.8M

Previous: 4.7M+1.9%
Medicare Membership

173.0K

Previous: 155.0K+11.6%
Marketplace Membership

276.0K

Previous: 353.0K-21.8%
Capital Expenditures

-$89M

Previous: -$81M-9.9%
Free Cash Flow

$156M

Previous: $149M+4.7%
Net Income

$245M

Previous: $230M+6.5%
Operating Income

$359M

Previous: $335M+7.2%
Gross Profit

$1.24B

Previous: $1.18B+5.3%
Cash & Equivalents

$5.57B

Previous: $4.24B+31.2%
Total Assets

$14.9B

Previous: $12.8B+16.2%
Stock-Based Comp

$33M

Previous: $23M+43.5%

Revenue & EPS history

Molina · Revenue · Quarterly

$8.55B

Q3 2023+7.8%vs Q3 2022
Beat estimate in 11 of 15 quarters(73%)
ActualEstimate

Revenue by segment

Molina · $8.04B total across 3 segments · Q2 2023

  • Medicaid
    $6.49B+2.9%
  • Medicare
    $1.04B+9.1%
  • Marketplace
    $513M-5.2%

Forward guidance

The Company affirms its full-year 2023 adjusted earnings per share guidance of at least $20.75, reflecting third quarter results that were largely consistent with the Company’s expectations, in addition to considerations of seasonality and conservatism.

Historical earnings impact

How earnings announcements have historically affected this stock's price.

Avg. return before/after earnings

Based on 20 quarterly earnings reports · overlaid with Q3 2023

Historical avgQ3 2023

+0.2%

Avg return

Earnings day

+1.6%

Avg return

5 days after

+2.9%

Avg return

30 days after

41%

27 / 66 earnings

Positive

+26.3%

Q1 2017

Best reaction

-25.5%

Q4 2025

Worst reaction

Earnings price reactions
QuarterReport dateReaction (Day 0)+5 days+30 days
Q1 2026+2.6%+21.2%+20.3%
Q4 2025-25.5%-30.6%-18.3%
Q3 2025-17.3%-16.5%-27.5%
Q2 2025+4.9%+8.8%+13.3%
Q1 2025-5.5%-3.7%-8.1%
Q4 2024-10.1%-13.9%+3.3%
Q3 2024+14.0%+11.0%+2.4%
Q2 2024+13.0%+16.1%+20.5%
Q1 2024-3.0%-5.3%-8.6%
Q4 2023+6.8%+9.9%+9.9%
Q3 2023-0.7%-1.7%+10.1%
Q2 2023-2.6%-3.5%+1.0%
Q1 2023+6.3%+9.4%-2.2%
Q4 2022-0.5%-1.1%-13.7%
Q3 2022-3.9%-2.0%-10.7%
Q2 2022+2.7%+5.3%+9.7%
Q1 2022-1.9%-4.7%-5.1%
Q4 2021-0.5%-0.0%+1.8%
Q3 2021-0.8%-0.5%-2.4%
Q2 2021-2.0%+5.4%+3.2%
Q1 2021+1.2%+2.2%+0.2%
Q4 2020+5.0%+5.0%+12.9%
Q3 2020-8.2%-2.5%+1.5%
Q2 2020-1.6%-0.5%-2.0%
Q1 2020+5.2%+9.9%+12.8%
Q4 2019+10.5%+13.3%+3.1%
Q3 2019-0.3%-4.4%+11.0%
Q2 2019-4.4%-7.0%-6.5%
Q1 2019+0.9%-0.2%+2.0%
Q4 2018-5.5%-1.1%+3.6%
Q3 2018-0.8%-0.9%+11.1%
Q2 2018+18.7%+23.1%+34.7%
Q1 2018-2.9%-1.2%+3.4%
Q4 2017-3.8%-8.1%-2.8%
Q3 2017+16.1%+13.7%+14.6%
Q2 2017-6.8%-12.4%-4.0%
Q1 2017+26.3%+30.8%+31.3%
Q4 2016-17.2%+1.6%-6.0%
Q3 2016-5.9%-7.0%-9.3%
Q2 2016+10.1%+8.1%+4.2%
Q1 2016-20.6%
Q4 2015-1.5%
Q3 2015-8.6%
Q2 2015+9.6%
Q1 2015+11.6%
Q4 2014+8.8%
Q3 2014+4.6%
Q2 2014-6.5%
Q1 2014+4.5%
Q4 2013-6.4%
Q3 2013-7.5%
Q2 2013-1.4%
Q1 2013+1.6%
Q4 2012+10.0%
Q3 2012+14.3%
Q2 2012-1.7%
Q1 2011-2.5%
Q1 2012+0.2%
Q4 2011-0.2%
Q1 2010-0.2%
Q4 2009-0.2%
Q3 2010+1.2%
Q3 2011+1.2%
Q2 2011-2.7%
Q4 2010-2.7%
Q2 2010-2.7%

Discussion

Share your read of this quarter. Sign-in carries your eToro identity.

Join the conversation

Sign in with eToro to post your read of this quarter and vote on others'.

Sign in with eToro